Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Harpoon Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16
Revenues4.80.70.0
            Revenue growth570.9%  
Cost of goods sold0.00.00.0
Gross profit4.80.70.0
            Gross margin100.0%100.0% 
Selling, general and administrative32.517.211.1
EBIT-27.7-16.50.0
            EBIT margin-583.7%-2334.5% 
Pre-tax income-27.4-16.8-11.4
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income-27.4-16.8-11.4
            Net margin-576.1%-2377.1% 
 
Diluted EPS($25.65)($18.81)($21.61)
Shares outstanding (diluted)1.10.90.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy